"Evaluation of clinicopathologic correlation of her2neu and activated AKT in metastatic 3+CB11 breast cancer and patient outcomes" by Grace Makari-Judson, MD

Article

Evaluation of clinicopathologic correlation of her2neu and activated AKT in metastatic 3+CB11 breast cancer and patient outcomes

All Scholarly Works

Grace Makari-Judson, MD, Baystate Health
Raavi Gupta, MD, Baystate Health
Christopher Otis, MD, Baystate Health

Document Type

Presentations, Research

Publication Date

4-1-2005

Citation Information

Ricketts R, Gupta R, Newsome B, Otis C, Makari-Judson G. Evaluation of clinicopathologic correlation of her2neu and activated AKT in metastatic 3+CB11 breast cancer and patient outcomes. American College of Physicians: Internal Medicine. San Francisco, CA. Apr 14-Apr 15, 2005.